Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Goldman Sachs Maintains Neutral on Twist Bioscience, Lowers Price Target to $43

Goldman Sachs Maintains Neutral on Twist Bioscience, Lowers Price Target to $43

Goldman Sachs analyst Matthew Sykes maintains Twist Bioscience (NASDAQ:TWST) with a Neutral and lowers the price target from $50 to $43.

February 6, 2023

1 minute read

Goldman Sachs analyst Matthew Sykes maintains Twist Bioscience (NASDAQ:TWST) with a Neutral and lowers the price target from $50 to $43.

Raymond James Maintains Outperform on Tritium DCFC, Lowers Price Target to $9

July 12, 9:34 AM

Raymond James analyst Pavel Molchanov maintains Tritium DCFC (NASDAQ:DCFC) with a Outperform and lowers the price target from $11 to $9.

July 5, 2:14 PM

Benchmark analyst Todd M.

March 2, 2:15 AM

Tesla Inc.

July 16, 9:52 AM

Tesla, Inc. (NASDAQ:TSLA) is scheduled to release its second-quarter results after the market closes on Wednesday. Ahead of…